BDBM502341 2-(S)- hydroxy-3- methyl-N-{4- [1-methyl-7- (1-methyl-1H- benzoimid- azole-2-yl)- [1,2,4]tri- azolo[4,3- a]quinoxaline- 4-ylamino]- butyl}-::US11028090, Example 234

SMILES CC(C)[C@H](O)C(=O)NCCCCNc1nc2cc(ccc2n2c(C)nnc12)-c1nc2ccccc2n1C

InChI Key InChIKey=LAXGFSHOPAIWHG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 502341   

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502341(2-(S)- hydroxy-3- methyl-N-{4- [1-methyl-7- (1-met...)
Affinity DataIC50: 6nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent